Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOCILIZUMAB-AAZG vs TOPOTECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOCILIZUMAB-AAZG vs TOPOTECAN: Safety Overview

Metric TOCILIZUMAB-AAZG TOPOTECAN
Total FAERS Reports 155 3,537
Deaths Reported 7 773
Death Rate 4.5% 21.9%
Hospitalizations 44 1,213
Average Patient Age 63.6 yrs 28.7 yrs
% Female Patients 81.3% 51.1%
FDA Approval Date N/A Aug 28, 2012
Manufacturer N/A Sandoz Inc
Route N/A ORAL
Marketing Status Prescription Prescription